Therefore, CD200R1 agonists are promising molecules that regulate neuroinflammation development in neurological disease, and CD200R1 might be a potential therapeutic target for the regulation of neuroinflammation in the acute stage of stroke. Here, CD200R1 is linked to nervous system disorder.